Guardian Pharmacy Services reported Q4 2024 revenue of $338.6M, beat analyst consensus of $323.1M by $15.5M. Diluted EPS came in at $0.24, beat the $0.21 consensus by $0.03.
Trailing eight quarters through Q4 2024
Common questions about Guardian Pharmacy Services's Q4 2024 earnings report.
Guardian Pharmacy Services (GRDN) reported Q4 2024 earnings on March 26, 2025 after market close.
Guardian Pharmacy Services reported revenue of $338.6M and diluted EPS of $0.24 for Q4 2024.
Revenue beat the consensus estimate of $323.1M by $15.5M. EPS beat the consensus estimate of $0.21 by $0.03.
You can read the 10-K periodic report (0001193125-25-064082) directly on SEC EDGAR. The filing index links above go to sec.gov.